the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Trump takes lead in US presidential race but battleground states still too close to call

ATLANTA: Republican Donald Trump was leading in the U.S. presidential election on Tuesday, broadly drawing more support than he did in his failed 2020 campaign, though the result remained unclear in battleground states that will decide the winner.

Trump, bidding to become the first former president to return to the White House in more than 100 years, had won 211 Electoral College votes compared with 145 for his Democratic rival, Vice President Kamala Harris, with a third of the vote counted.

With Trump holding leads in battleground states Georgia and North Carolina, Harris’ clearest path to victory remained through the “Blue Wall” of Michigan, Pennsylvania and Wisconsin. A candidate needs a total of at least 270 votes in the 538-member, state-by-state Electoral College to claim the presidency.

Decision Desk HQ was alone in projecting Trump would win Georgia and North Carolina. Other media outlets and Edison had yet to call the two races.

Trump picked up much more support in the polls from Hispanics, traditionally Democratic voters, and among lower-income households that have keenly felt the sting of price rises since the last presidential election in 2020.

Trump won 45% of Hispanic voters nationwide, trailing Harris with 53% but up 13 percentage points from 2020, according to the provisional exit polls.

Currency and bond markets appeared to bet on Trump returning to power.

But the race, as expected, was coming down to seven swing states: Arizona, Georgia, Michigan, Nevada, North Carolina, Pennsylvania and Wisconsin.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings